Breaking News Instant updates and real-time market news.

SPLK

Splunk

$128.68

-7.12 (-5.24%)

07:58
05/24/19
05/24
07:58
05/24/19
07:58

Barclays sees short-term weakness in Splunk as long-term opportunity

While Splunk continued its tradition of beating and raising sales numbers, a bookings deceleration and a guide-down on operating cash flow for the fiscal year "opens up questions," Barclays analyst Raimo Lenschow tells investors in a post-earnings research note titled "Bookings Growth of +30% Not Too Shabby." The analyst, however, believes bookings growth of 33% for a $2B-plus revenue company is "still impressive." Nonetheless, he thinks the operating cash flow revision driven by $80M of un-invoiced contracts will weigh on the shares. Without a clear path to calculating this un-invoiced number, investors will be split on taking management at their word, Lenschow contends. He expects Splunk shares to be under pressure in the short-term, but thinks this could create a buying opportunity for longer term investors. Lenschow keeps an Overweight rating on the name with a $158 price target.

  • 13

    Jun

  • 09

    Jul

SPLK Splunk
$128.68

-7.12 (-5.24%)

05/16/19
PIPR
05/16/19
NO CHANGE
Target $160
PIPR
Overweight
Splunk should be bought ahead of Q1 results, says Piper Jaffray
Piper Jaffray analyst Alex Zukin says his channel checks suggest a favorable start to Splunk's 2019, with security continuing to drive customer activity. The analyst sees a 5% beat when the company reports on May 23, in line with previous Q1's, and his research continues to suggest a "robust demand environment and solid fundamentals." He would be adding to positions in front of the quarter and reiterates an Overweight rating on Splunk shares with a $160 price target.
05/23/19
MUFG
05/23/19
NO CHANGE
Target $159
MUFG
Overweight
Splunk price target raised to $159 from $153 at MUFG
MUFG analyst Stephen Bersey raised his price target on Splunk to $159 and kept his Overweight rating after its Q1 earnings beat, saying the company is sustaining its "impressive" operating performance with "strong" revenue growth and margin expansion. The analyst expects Splunk to continue to benefit from end market demand in FY20 and believes that its product portfolio makes it well positioned in the enterprise analytics and security markets.
05/24/19
JEFF
05/24/19
NO CHANGE
Target $157
JEFF
Buy
Splunk exceeded most metrics for Q1, says Jefferies
Splunk exceeded most metrics for fiscal Q1, other than a shortfall in long-term deferred, and guided fiscal Q2 above the Street, Jefferies analyst John DiFucci tells investors in a research note. The company's move to ratable revenue will weigh on cash flow this year, however, as its guidance of $250M was over $100M below last quarter's outlook, the analyst adds. DiFucci says that while his analysis indicates Splunk's business momentum moderated in Q1, he continues to view the company as a "unique asset." The analyst maintains a Buy rating on the shares with a $157 price target.
05/24/19
BMOC
05/24/19
NO CHANGE
Target $157
BMOC
Outperform
Splunk price target lowered to $157 from $162 at BMO Capital
BMO Capital analyst Keith Bachman lowered his price target on Splunk to $157 to reflect "some uncertainty" around the company's growth rates and free cash flow penetration, even though its Q1 revenue growth accelerated to 36% from 35% in the prior quarter and its FY20 guidance was raised slightly. The analyst also keeps his Outperform rating on Splunk, saying the company has "multiple avenues" toward expansion of its total addressable market that include Security, Internet of Things, and Business Intelligence segments. Bachman further contends that the valuation on the stock is still "attractive" relative to the company's growth rate.

TODAY'S FREE FLY STORIES

FBMS

First Bancshares

$33.70

-0.4 (-1.17%)

20:54
01/21/20
01/21
20:54
01/21/20
20:54
Hot Stocks
First Bancshares raises quarterly dividend to 10c from 8c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBMS

First Bancshares

$33.70

-0.4 (-1.17%)

20:54
01/21/20
01/21
20:54
01/21/20
20:54
Earnings
First Bancshares reports Q4 EPS 72c, consensus 74c »

Reports Q4 NII $33.8M vs.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NNVC

NanoViricides

$8.10

4.76 (142.51%)

20:39
01/21/20
01/21
20:39
01/21/20
20:39
Syndicate
NanoViricides 2.5M share Secondary priced at $3.00 »

Aegis is acting as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$89.76

0.76 (0.85%)

, BKR

Baker Hughes

$22.72

-0.9 (-3.81%)

20:25
01/21/20
01/21
20:25
01/21/20
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

ABT

Abbott

$89.76

0.76 (0.85%)

BKR

Baker Hughes

$22.72

-0.9 (-3.81%)

ALLY

Ally Financial

$30.25

-0.19 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 23

    Mar

MDT

Medtronic

$120.30

1.32 (1.11%)

20:03
01/21/20
01/21
20:03
01/21/20
20:03
Recommendations
Medtronic analyst commentary at Piper Sandler »

Medtronic price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 18

    Feb

CNC

Centene

$65.48

0.96 (1.49%)

, WCG

WellCare

$340.52

3.55 (1.05%)

19:49
01/21/20
01/21
19:49
01/21/20
19:49
Hot Stocks
WellCare, Centene satisfy merger requirements »

Centene (CNC) and…

CNC

Centene

$65.48

0.96 (1.49%)

WCG

WellCare

$340.52

3.55 (1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

  • 13

    Feb

AAPL

Apple

$316.39

-2.27 (-0.71%)

, HNHPF

Hon Hai Precision

$0.00

(0.00%)

19:17
01/21/20
01/21
19:17
01/21/20
19:17
Periodicals
Apple suppliers to start making new low-cost iPhone in February, Bloomberg says »

Apple (AAPL) suppliers…

AAPL

Apple

$316.39

-2.27 (-0.71%)

HNHPF

Hon Hai Precision

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

EFC

Ellington Financial

$18.85

0.13 (0.69%)

19:12
01/21/20
01/21
19:12
01/21/20
19:12
Syndicate
Ellington Financial 4.6M share Spot Secondary priced at $18.29 »

Morgan Stanley, Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

MRVSY

Minerva SA

$0.00

(0.00%)

18:59
01/21/20
01/21
18:59
01/21/20
18:59
Downgrade
Minerva SA rating change at Goldman Sachs »

Minerva SA downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRPBF

Grupo Lala

$0.00

(0.00%)

18:57
01/21/20
01/21
18:57
01/21/20
18:57
Downgrade
Grupo Lala rating change at Goldman Sachs »

Grupo Lala downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCU

Compania Cervecerias

$19.00

-0.33 (-1.71%)

18:53
01/21/20
01/21
18:53
01/21/20
18:53
Downgrade
Compania Cervecerias rating change at Goldman Sachs »

Compania Cervecerias…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRPBF

Grupo Lala

$0.00

(0.00%)

18:50
01/21/20
01/21
18:50
01/21/20
18:50
Upgrade
Grupo Lala rating change at Goldman Sachs »

Grupo Lala upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPAGF

Gruma

$0.00

(0.00%)

18:48
01/21/20
01/21
18:48
01/21/20
18:48
Upgrade
Gruma rating change at Goldman Sachs »

Gruma upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KOF

Coca-Cola Femsa

$62.52

0.41 (0.66%)

18:47
01/21/20
01/21
18:47
01/21/20
18:47
Upgrade
Coca-Cola Femsa rating change at Goldman Sachs »

Coca-Cola Femsa upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOGI

Logitech

$47.77

1.2 (2.58%)

18:46
01/21/20
01/21
18:46
01/21/20
18:46
Hot Stocks
Logitech CEO: We're growing all three of our businesses at a healthy clip »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

NAVI

Navient

$13.86

-0.01 (-0.07%)

, IBM

IBM

$139.15

0.84 (0.61%)

18:44
01/21/20
01/21
18:44
01/21/20
18:44
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS:…

NAVI

Navient

$13.86

-0.01 (-0.07%)

IBM

IBM

$139.15

0.84 (0.61%)

COF

Capital One

$102.29

-1.85 (-1.78%)

FBK

FB Financial

$38.20

-0.66 (-1.70%)

NFLX

Netflix

$338.24

-1.32 (-0.39%)

MNLO

Menlo Therapeutics

$6.48

-0.17 (-2.56%)

CIT

CIT Group

$45.23

-1.17 (-2.52%)

SKT

Tanger Factory

$15.93

0.56 (3.64%)

ETN

Eaton

$94.51

-1.19 (-1.24%)

SUPN

Supernus

$24.70

0.26 (1.06%)

ZION

Zions Bancorp

$49.93

-0.81 (-1.60%)

IBKR

Interactive Brokers

$50.89

0.7 (1.39%)

AMTD

TD Ameritrade

$50.76

0.25 (0.49%)

FULT

Fulton Financial

$17.26

-0.07 (-0.40%)

UAL

United Airlines

$85.84

-3.84 (-4.28%)

ADAP

Adaptimmune

$4.14

-0.38 (-8.41%)

BPMC

Blueprint Medicines

$79.69

-1.46 (-1.80%)

ELAN

Elanco

$30.64

0.65 (2.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 21

    Jan

  • 21

    Jan

  • 21

    Jan

  • 21

    Jan

  • 21

    Jan

  • 21

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 28

    Jan

  • 04

    Feb

  • 06

    Feb

  • 06

    Feb

  • 14

    Feb

  • 19

    Feb

  • 26

    Feb

  • 22

    Jan

  • 23

    Jan

  • 23

    Jan

SUPN

Supernus

$24.70

0.26 (1.06%)

18:35
01/21/20
01/21
18:35
01/21/20
18:35
Hot Stocks
Supernus: FDA accepts for review NDA for SPN-812 »

Supernus announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$338.24

-1.32 (-0.39%)

18:31
01/21/20
01/21
18:31
01/21/20
18:31
Hot Stocks
Netflix says doesn't want to 'exploit' users with advertising »

Says mobile-only plans in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

COST

Costco

$313.28

8.6 (2.82%)

18:25
01/21/20
01/21
18:25
01/21/20
18:25
Hot Stocks
Costco CEO: We're a volume company, not a margin company »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 05

    Mar

NFLX

Netflix

$338.24

-1.32 (-0.39%)

18:24
01/21/20
01/21
18:24
01/21/20
18:24
Hot Stocks
Netflix says plans to increase content spending across the board »

Says plans to increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

PBR

Petrobras

$14.76

-0.41 (-2.70%)

18:23
01/21/20
01/21
18:23
01/21/20
18:23
Hot Stocks
Petrobras says CARF issued 'unfavorable' decision on tax proceeding »

Petrobras said that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMBI

First Midwest

$21.58

-0.725 (-3.25%)

18:15
01/21/20
01/21
18:15
01/21/20
18:15
Earnings
First Midwest reports Q4 EPS 51c, consensus 50c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

NFLX

Netflix

$338.24

-1.32 (-0.39%)

, DIS

Disney

$143.53

-0.72 (-0.50%)

18:14
01/21/20
01/21
18:14
01/21/20
18:14
Hot Stocks
Netflix says Oscar-nominated original films 'very popular' with users as well »

Netflix (NFLX) says…

NFLX

Netflix

$338.24

-1.32 (-0.39%)

DIS

Disney

$143.53

-0.72 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 04

    Feb

MDT

Medtronic

$120.30

1.32 (1.11%)

18:12
01/21/20
01/21
18:12
01/21/20
18:12
Hot Stocks
Medtronic: Trial shows 'superior' back pain relief with DTM SCS »

Medtronic announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 18

    Feb

NFLX

Netflix

$338.24

-1.32 (-0.39%)

, DIS

Disney

$143.53

-0.72 (-0.50%)

18:07
01/21/20
01/21
18:07
01/21/20
18:07
Hot Stocks
Netflix says seasonality from Q1 to Q2 likely to be 'more balanced' »

Netflix (NFLX) says Q1…

NFLX

Netflix

$338.24

-1.32 (-0.39%)

DIS

Disney

$143.53

-0.72 (-0.50%)

GOOG

Alphabet

$1,484.92

4.64 (0.31%)

GOOGL

Alphabet Class A

$1,482.70

3.58 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 22

    Jan

  • 22

    Jan

  • 23

    Jan

  • 27

    Jan

  • 03

    Feb

  • 03

    Feb

  • 04

    Feb

  • 10

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.